Phathom Pharmaceuticals is a biopharmaceutical company developing and commercializing treatments for gastrointestinal diseases, including its acid-suppression drug vonoprazan.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Carlyle Group Inc. (auto-surfaced) | 48 | Holds (flat) | 3,496,808 | $57,977,077 | 0.4% |
| Louis Bacon / Moore | 55 | Holds (flat) | 600,000 | $9,954,000 | 0.1% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.